SCHEMBL6175142

SCHEMBL6175142

CC(c1ccnc(C(N)=O)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 3/20 0.38
HRH4 Q9H3N8 2/20 0.33
LMNA P02545 2/20 0.33
TRPV3 Q8NET8 2/20 0.32
CCR7 P32248 1/20 0.31
CCR6 P51684 1/20 0.31
NR1H3 Q13133 2/20 0.31
NR1H2 P55055 1/20 0.31
DPP4 P27487 1/20 0.31
DPP7 Q9UHL4 1/20 0.31
JAK2 O60674 2/20 0.31
JAK1 P23458 2/20 0.31
MT-CO2 P00403 1/20 0.31
ALOX5 P09917 1/20 0.31
KIF11 P52732 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SYK P43405 1/20 0.30
LARS1 Q9P2J5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173577 0.88 IGF1R (0.39) IGF1RHRH4LMNATRPV3MAPK1
SCHEMBL6174834 0.86 GRM1 (0.39) IGF1RLMNAMAPK1SMN1; SMN2EPHX2
SCHEMBL6175008 0.86 IGF1R (0.39) IGF1RHRH4LMNATRPV3MAPK1
SCHEMBL6174486 0.84 IGF1R (0.38) IGF1RHRH4LMNATRPV3NR1H3
SCHEMBL6175530 0.84 IGF1R (0.37) IGF1RHRH4LMNATRPV3SMN1; SMN2
SCHEMBL6172969 0.83 DHODH (0.38) IGF1RSMN1; SMN2
SCHEMBL6173894 0.83 IGF1R (0.37) IGF1RHRH4LMNATRPV3KIF11
SCHEMBL6172236 0.83 IGF1R (0.39) IGF1RHRH4LMNATRPV3MAPK1
SCHEMBL6177752 0.82 IGF1R (0.37) IGF1RLMNATRPV3
SCHEMBL6173484 0.81 HRH4 (0.38) IGF1RHRH4LMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed